BOSTON (AP) — BOSTON (AP) — Vertex Pharmaceuticals Inc. (VRTX) on Monday reported third-quarter profit of $653.6 million.
On a per-share basis, the Boston-based company said it had net income of $2.56. Earnings, adjusted for one-time gains and costs, came to $4.76 per share.
The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of $4.92 per share.
The drugmaker posted revenue of $3.44 billion in the period, beating Street forecasts. Seven analysts surveyed by Zacks expected $3.4 billion.
Vertex expects full-year revenue in the range of $13.15 billion to $13.25 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VRTX at https://www.zacks.com/ap/VRTX